52 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
22 Jan 19
Current report (foreign)
4:43pm
and Corporate Governance Committee of the Company.
Does not include 100,000 Shares held by Mr. Hall’s wife over which Mr. Hall does not exercise control … and Corporate Governance Committee, currently consisting of David Hall, Peter Lewis and Geoff MacKay on both committees.
- 8 -
Management recommends
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
18 Nov 21
Notice of Annual General and Special Meeting of Shareholders
10:36am
) Member of the Nominating, Compensation and Corporate Governance Committee of the Company.
(5) Member of the Operations Committee of the Company.
(6 … with a standing Audit Committee, a Nominating, Compensation and Corporate Governance Committee and an Operations Committee. David Hall, Peter Lewis
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
and Corporate Governance Committee of the Company.
(5) Does not include 100,000 Shares held by Mr. Hall's wife over which Mr. Hall does not exercise … and Corporate Governance Committee, currently consisting of David Hall, Peter Lewis and Geoff MacKay on both committees. As Geoff MacKay
6-K
REPCF
Replicel Life Sciences Inc.
26 Oct 11
Current report (foreign)
12:00am
by the directors or executive officers of the Company.
CORPORATE GOVERNANCE
General
The Board believes that good corporate governance improves corporate … performance and benefits all shareholders. National Policy 58-201 Corporate Governance Guidelines, as adopted by the British Columbia Securities Commission
6-K
REPCF
Replicel Life Sciences Inc.
17 May 12
Current report (foreign)
12:00am
of the Company.
CORPORATE GOVERNANCE
General
The Board believes that good corporate governance improves corporate performance and benefits all … shareholders. National Policy 58-201 Corporate Governance Guidelines, as adopted by the British Columbia Securities Commission, provides non-prescriptive
6-K
e6uev6rnefblnsm7vbb7
23 May 13
Current report (foreign)
12:00am
6-K
wftyz50zq i9cv51yo7
7 Jun 07
Current report (foreign)
12:00am
6-K
lkc33zav oc7
24 Nov 10
Current report (foreign)
12:00am
6-K
dpzs3qgqrp2dg1
21 Sep 06
Current report (foreign)
12:00am
6-K
EX-99.4
ycrp71av3e0uz n4uyr
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
2gpv2t5lelwozntp
15 Oct 09
Current report (foreign)
12:00am
6-K
EX-99.2
grv4m5
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
20-F/A
j7mpdz0obx6lf92u8 zy
12 Jan 18
Annual report (foreign) (amended)
12:00am
6-K
EX-99.1
2t8fn2
13 Nov 20
Notice of Annual General and Special Meeting of Shareholders
12:00am